Skip to main content

TableĀ 1 Characteristics of the study participants

From: QuantiFERON-TB Gold In-tube test for the diagnosis of active and latent tuberculosis in selected health facilities of Addis Ababa, Ethiopia

Category

Tuber suspects (Nā€‰=ā€‰136)

LTB (Nā€‰=ā€‰66)

Sex, N (%)

Ā Female

58 (42.6)

27 (50.9)

Ā Male

78 (57.4)

26 (49.1)

Age, median in years (range)

30 (18ā€“80)

27 (18ā€“77)

CD4 count (Cells per Āµl), N (%)

Ā CD4ā€‰<ā€‰200

25 (18.4)

0 (%)

Ā CD4ā€‰ā‰„ā€‰200

111 (81.6)

66 (100)

BMI category (kg/m2), N (%)

Ā BMIā€‰<ā€‰18.5

41 (30.1)

7 (10.6)

Ā 18.5ā€‰<ā€‰BMIā€‰<ā€‰24.99

74 (54.4)

43 (65.2)

Ā BMIā€‰ā‰„ā€‰25

21 (15.4)

16 (24.2)

BCG, N (%)

Ā Vaccinated

40 (29.4)

42 (63.6)

Ā Not vaccinated

96 (70.6)

24 (36.6)

HIV status

Ā Positive

21 (15.4)

3 (4.5)

Ā Negative

115 (84.6)

63 (95.5)

Smear status, N (%)

Ā Positive

12 (8.8%)

NAa

Ā Negative

124 (91.2%)

NA

Culture, N (%)

Ā Positive

37 (27.2)

NA

Ā Negative

99 (72.8)

NA

Blood with sputum, N (%)

28 (20.6)

NA

Breath shortness, N (%)

90 (66.2)

NA

Night sweats, N (%)

99 (72.8)

NA

Chest pain, N (%)

110 (80.9)

NA

Loss of weight, N (%)

91 (66.9)

NA

  1. aNot applicable for testing latent tuberculosis group